Sydney - Wednesday - May 16: (RWE Australian Business News) -
Sunshine Heart (SHC) announced today it had successfully completed the
development of the next generation C-PulseSystem for use in the US
Feasibility Clinical Trial scheduled to commence in the second half of
2007.
The new C-Pulse system includes a proprietary Wearable C-Pulse
Driver that is significantly enhanced from the version that has been
used during the Australian and New Zealand Pilot Clinical Trial. It will
provide patients with greater freedom and ultimately an improved quality
of life.
VCR
ventracor limited
